NO20074661L - Anvendelse av en forbindelse - Google Patents

Anvendelse av en forbindelse

Info

Publication number
NO20074661L
NO20074661L NO20074661A NO20074661A NO20074661L NO 20074661 L NO20074661 L NO 20074661L NO 20074661 A NO20074661 A NO 20074661A NO 20074661 A NO20074661 A NO 20074661A NO 20074661 L NO20074661 L NO 20074661L
Authority
NO
Norway
Prior art keywords
compound
desmethoxyrapamycin
och
medicament
disease
Prior art date
Application number
NO20074661A
Other languages
English (en)
Inventor
Matthew Alan Gregory
Rose Mary Sheridan
Mingqiang Zhang
Original Assignee
Biotica Tech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0504995.2A external-priority patent/GB0504995D0/en
Priority claimed from GB0522829A external-priority patent/GB0522829D0/en
Application filed by Biotica Tech Ltd filed Critical Biotica Tech Ltd
Publication of NO20074661L publication Critical patent/NO20074661L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Anvendelse av en 39-desmetoksyrapamycinanalog med formelen der R, representerer (H, H) eller =0 og R, og Rhver uavhengig representerer H, OH eller OCH; eller et farmasøytisk akseptabelt salt av samme, i framstilling av et medikament for behandling av en medisinsk tilstand som resulterer fra nerveskade eller sykdom.
NO20074661A 2005-03-11 2007-09-13 Anvendelse av en forbindelse NO20074661L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB0504995.2A GB0504995D0 (en) 2005-03-11 2005-03-11 Use of a compound
US11/097,605 US7183289B2 (en) 2005-03-11 2005-04-01 39-desmethoxyrapamycin, compositions and methods of use thereof
GB0522829A GB0522829D0 (en) 2005-11-09 2005-11-09 Use of a compound
PCT/GB2006/000834 WO2006095173A2 (en) 2005-03-11 2006-03-10 Medical uses of 39-desmethoxyrapamycin and analogues thereof

Publications (1)

Publication Number Publication Date
NO20074661L true NO20074661L (no) 2007-10-30

Family

ID=36659697

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20074661A NO20074661L (no) 2005-03-11 2007-09-13 Anvendelse av en forbindelse

Country Status (6)

Country Link
EP (1) EP1896018A2 (no)
KR (1) KR20070116868A (no)
AU (1) AU2006221774A1 (no)
CA (1) CA2599547A1 (no)
NO (1) NO20074661L (no)
WO (1) WO2006095173A2 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0504994D0 (en) 2005-03-11 2005-04-20 Biotica Tech Ltd Novel compounds
GB0504995D0 (en) * 2005-03-11 2005-04-20 Biotica Tech Ltd Use of a compound
US20180258100A1 (en) * 2015-08-28 2018-09-13 Matthew Alan Gregory RAPAMYCIN ANALOGS SHOWING IMPROVED mTORC1 SPECIFICITY
CN111760015A (zh) * 2020-01-21 2020-10-13 中南大学 米卡芬净在制备神经保护药物中的应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5206018A (en) * 1978-11-03 1993-04-27 Ayerst, Mckenna & Harrison, Inc. Use of rapamycin in treatment of tumors
US5023262A (en) 1990-08-14 1991-06-11 American Home Products Corporation Hydrogenated rapamycin derivatives
US5221670A (en) 1990-09-19 1993-06-22 American Home Products Corporation Rapamycin esters
US5138051A (en) 1991-08-07 1992-08-11 American Home Products Corporation Rapamycin analogs as immunosuppressants and antifungals
WO1992021341A1 (en) 1991-05-31 1992-12-10 Pfizer Inc. Use of rapamycin prodrugs as immunosuppressant agents
ZA935112B (en) 1992-07-17 1994-02-08 Smithkline Beecham Corp Rapamycin derivatives
GB9221220D0 (en) 1992-10-09 1992-11-25 Sandoz Ag Organic componds
US5373014A (en) 1993-10-08 1994-12-13 American Home Products Corporation Rapamycin oximes
US5391730A (en) 1993-10-08 1995-02-21 American Home Products Corporation Phosphorylcarbamates of rapamycin and oxime derivatives thereof
US5378836A (en) 1993-10-08 1995-01-03 American Home Products Corporation Rapamycin oximes and hydrazones
JP3745772B2 (ja) 1993-12-17 2006-02-15 ノバルティス アクチエンゲゼルシャフト 免疫抑制剤として有用なラパマイシン誘導体
US5362718A (en) 1994-04-18 1994-11-08 American Home Products Corporation Rapamycin hydroxyesters
US5563145A (en) 1994-12-07 1996-10-08 American Home Products Corporation Rapamycin 42-oximes and hydroxylamines
DK0833828T3 (da) 1995-06-09 2003-03-17 Novartis Ag Rapamycinderivater
US5780462A (en) 1995-12-27 1998-07-14 American Home Products Corporation Water soluble rapamycin esters
CA2261666C (en) 1996-07-30 2010-09-14 Novartis Ag Pharmaceutical compositions for the treatment of transplant rejection, autoimmune or inflammatory conditions comprising cyclosporin a and 40-0-(2-hydroxiethyl)-rapamycin
US6015815A (en) 1997-09-26 2000-01-18 Abbott Laboratories Tetrazole-containing rapamycin analogs with shortened half-lives
EP2277898A3 (en) * 2002-07-16 2011-06-01 Biotica Technology Limited Rapamycin analogues
GB0417852D0 (en) * 2004-08-11 2004-09-15 Biotica Tech Ltd Production of polyketides and other natural products
GB0504994D0 (en) * 2005-03-11 2005-04-20 Biotica Tech Ltd Novel compounds

Also Published As

Publication number Publication date
WO2006095173A2 (en) 2006-09-14
WO2006095173A3 (en) 2007-01-11
AU2006221774A1 (en) 2006-09-14
EP1896018A2 (en) 2008-03-12
KR20070116868A (ko) 2007-12-11
CA2599547A1 (en) 2006-09-14

Similar Documents

Publication Publication Date Title
HRP20090281T1 (en) 1,2,3,4-tetrasubstituted indole for the treatment of respiratory diseases
WO2006067165A3 (en) Indolidone derivatives for the treatment or prevention of fibrotic diseases
CY1115719T1 (el) Νεοι φαρμακευτικοι συνδυασμοι για τη θεραπεια νοσων των αναπνευστικων οδων
MX2009006742A (es) Inhibidores acilaminopirazoles como fgfr.
DE602006009095D1 (en) Diacylglycerol-acyltransferase-hemmer
WO2006098918A3 (en) Substituted gamma lactams as therapeutic agents
UY27092A1 (es) Derivados del novedoso carbamato de quinuclidina y las composiciones medicinales que los contienen
WO2007082808A3 (en) Thiazoles as 11 beta-hsd1 inhibitors
MY149622A (en) Pyrazoles as 11-beta-hsd-1
NO20082643L (no) Isokinolinaminopyrazolderivater, deres fremstilling og anvendelse som farmasoytiske midler for behandling av kreft
TW200736223A (en) N-(pyridin-2-yl)-sulfonamide derivatives
NO20081315L (no) Benzokinazolinderivater og deres anvendelse ved behandling av benlidelser
EA200601837A1 (ru) Бензоксазины для лечения заболеваний дыхательных путей
MX2007012212A (es) 1h-pirazol 4-carboxilamidas, su preparacion y su uso como 11-beta-hidroxiesteroide deshidrogenasa.
NO20064010L (no) Indazolderivater og farmasoytiske preparater inneholdelse slike
NO20082445L (no) Neuropeptid-2 reseptor-agonister
MX2009001659A (es) Compuestos de 2,5-dihidroxibenceno para el tratamiento de rosacea.
UA107578C2 (uk) Комбінована терапія при лікуванні діабету
MY148125A (en) Compounds
WO2007057221A3 (en) Pharmaceutical compositions for the treatment of inflammatory and obstructive airways diseases
UA83233C2 (ru) Замещенный 2-аминотетралин для лечения депрессии
EP2639229A3 (en) Thiazole Derivative and use thereof as VAP-1 Inhibitor
EA200602016A1 (ru) ПОРОШКОВЫЕ КОМПОЗИЦИИ ДЛЯ ИНГАЛЯЦИИ, СОДЕРЖАЩИЕ ЭНАНТИОМЕРНОЧИСТЫЕ β-АГОНИСТЫ
NO20082112L (no) 3-Amino-2-arylpropylazaindoler og deres anvendelse
DK1814848T3 (da) 2,3,4-substitueret-cyclopentanoner som terapeutiske midler

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application